Integrated BioPharma
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Integrated BioPharma's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 1% to $50,317,000. The net income raised on $112,000 and profit margin reached 0%. Total operating expenses were $3,633,000.

Profit Margin

Integrated BioPharma, Inc. (OTC:INBP): Profit margin
2015 37.48M 735K 1.96%
2016 42.21M 958K 2.27%
2017 46.95M 2.34M 5%
2018 43.71M 679K 1.55%
2019 49.97M 1.68M 3.38%
2020 52.76M 4.10M 7.78%
2021 63.55M 8.01M 12.61%
2022 56.24M 3.83M 6.82%
2023 50.67M -34K -0.07%
2024 50.31M 112K 0.22%

INBP Income Statement (2015 – 2024)

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue
Revenue
50.31M50.67M56.24M63.55M52.76M49.97M43.71M46.95M42.21M37.48M
Cost of revenue
46.43M46.61M49.69M54.07M46.04M43.75M38.72M40.28M36.71M33.09M
Gross profit
3.88M4.06M6.55M9.48M6.72M6.22M4.98M6.66M5.50M4.39M
Operating exp.
Research and development
0000000000
Selling and marketing
00000017K0133K0
Total operating expenses
3.63M3.94M3.80M3.69M3.46M3.51M3.29M3.48M3.39M3.46M
Operating income
251K120K1.96M5.78M2.38M2.70M1.69M3.18M2.11M933K
Other income (expenses), net
17K-20K631K1.46M-171K-662K237K-1.33M28K-64K
Income before tax
268K100K2.59M7.24M3.08M2.04M1.00M1.85M1.18M869K
Income tax expense
156K134K-1.24M-766K-1.02M354K326K-490K231K134K
Net income
112K-34K3.83M8.01M4.10M1.68M679K2.34M958K735K
Earnings per share
Basic EPS
0.00-0.000.130.270.140.050.020.110.050.03
Diluted EPS
0.00-0.000.120.250.130.050.020.10.050.02
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source